What AI says about GeneSilico

GeneSilico provides an AI-powered platform that builds a patient-specific cancer Digital Twin to simulate tumor response and resistance to all treatment options before dosing. It offers a suite of AI agents and a unified Oncology Clinical Control Plane that orchestrates care, integrates with EHRs, and ranks therapies based on digital twin predictions. It also enables AI-driven drug discovery and continuous, point-of-care evidence generation across hospitals and CRO networks, delivering auditable efficacy data from molecule to patient.